USA: Genéricos, una duda en el camino...

Generic prescription drugs saved U.S. consumers $931B over past decade

September 22, 2011 | Rene Letourneau, Managing Editor

WASHINGTON – Use of generic prescription drugs in the United States has saved consumers and the healthcare system $931 billion over the last 10 years, according to a new report from the Generic Pharmaceutical Association (GPhA).

In its recent report “Savings: An Economic Analysis of Generic Drug Usage in the U.S.,” the GPhA claims that in 2010 generic drug use generated nearly $158 billion in savings, an average of $3 billion every week. The report is based on independently conducted analysis, produced for GPhA by the IMS Institute for Healthcare Informatics and IMS Health. (Más)

A veces si...

• In 2010 alone, generic use generated more than $157 billion in savings.

• The Medicaid system could save more than $1.3 billion annually by increasing generic use by just two percentage points.

• Savings from newer generic medicines - those that have entered the market since 2001 - continue to increase exponentially and account for more than one-third of the total savings.

• Generic products for nervous system and cardiovascular treatments alone account for 62 percent of the cost savings.

• Despite having nearly seven times as many products on the market, generic medications still accounted for less drug spending than branded products with generic competition.

• Over the past 10 years, patent settlements have resulted in billions of dollars in savings as dozens of first-time generics have come to market prior to patents expiring on the counterpart brand drugs.

A veces NO...
.